Financial Instruments and Fair Value Measurements (Concentration of Credit and Other Risks, Net Sales and Accounts Receivable) (Details)	3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended			12 Months Ended	9 Months Ended	12 Months Ended	9 Months Ended	12 Months Ended	3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended
	Jun. 28, 2013 Net Sales Attributable to Distributors Cardinal Health, Inc.	Jun. 29, 2012 Net Sales Attributable to Distributors Cardinal Health, Inc.	Jun. 28, 2013 Net Sales Attributable to Distributors Cardinal Health, Inc.	Jun. 29, 2012 Net Sales Attributable to Distributors Cardinal Health, Inc.	Jun. 28, 2013 Net Sales Attributable to Distributors McKesson Corporation	Jun. 29, 2012 Net Sales Attributable to Distributors McKesson Corporation	Jun. 28, 2013 Net Sales Attributable to Distributors McKesson Corporation	Jun. 29, 2012 Net Sales Attributable to Distributors McKesson Corporation	Jun. 28, 2013 Net Sales Attributable to Distributors Amerisource Bergen Corporation	Jun. 29, 2012 Net Sales Attributable to Distributors Amerisource Bergen Corporation	Jun. 28, 2013 Net Sales Attributable to Distributors Amerisource Bergen Corporation	Jun. 29, 2012 Net Sales Attributable to Distributors Amerisource Bergen Corporation	Jun. 28, 2013 Accounts Receivable Attributable to Distributors Cardinal Health, Inc.	Sep. 28, 2012 Accounts Receivable Attributable to Distributors Cardinal Health, Inc.	Jun. 28, 2013 Accounts Receivable Attributable to Distributors McKesson Corporation	Sep. 28, 2012 Accounts Receivable Attributable to Distributors McKesson Corporation	Jun. 28, 2013 Accounts Receivable Attributable to Distributors Amerisource Bergen Corporation	Sep. 28, 2012 Accounts Receivable Attributable to Distributors Amerisource Bergen Corporation	Jun. 28, 2013 Net Sales Attributable to Products Optiray (CMDS)	Jun. 29, 2012 Net Sales Attributable to Products Optiray (CMDS)	Jun. 28, 2013 Net Sales Attributable to Products Optiray (CMDS)	Jun. 29, 2012 Net Sales Attributable to Products Optiray (CMDS)	Jun. 28, 2013 Net Sales Attributable to Products Acetaminophen products (API)	Jun. 29, 2012 Net Sales Attributable to Products Acetaminophen products (API)	Jun. 28, 2013 Net Sales Attributable to Products Acetaminophen products (API)	Jun. 29, 2012 Net Sales Attributable to Products Acetaminophen products (API)	Jun. 28, 2013 Net Sales Attributable to Products Ultra-Technekow DTE (Nuclear Imaging)	Jun. 29, 2012 Net Sales Attributable to Products Ultra-Technekow DTE (Nuclear Imaging)	Jun. 28, 2013 Net Sales Attributable to Products Ultra-Technekow DTE (Nuclear Imaging)	Jun. 29, 2012 Net Sales Attributable to Products Ultra-Technekow DTE (Nuclear Imaging)
Concentration Risk [Line Items]
Concentration risk, percentage	16.00%	18.00%	19.00%	18.00%	7.00%	8.00%	13.00%	11.00%	10.00%	6.00%	8.00%	7.00%	19.00%	19.00%	18.00%	20.00%	14.00%	10.00%	16.00%	17.00%	15.00%	17.00%	11.00%	11.00%	10.00%	11.00%	8.00%	10.00%	9.00%	10.00%